Impact of SGLT2i and GLP1 agonists on prostate cancer incidence and outcomes: A real-world propensity score–matched cohort study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162678455
Cites:
Cited by:
Related to:
